370 related articles for article (PubMed ID: 16239983)
1. Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.
Talajic M; Roy D
Can J Cardiol; 2005 Sep; 21 Suppl B():19B-25B. PubMed ID: 16239983
[TBL] [Abstract][Full Text] [Related]
2. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].
Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic approaches to rhythm versus rate control in atrial fibrillation--where are we now?
Wyse DG
Int J Cardiol; 2006 Jun; 110(3):301-12. PubMed ID: 16516313
[TBL] [Abstract][Full Text] [Related]
4. [Antiarrhythmic drugs in paroxysmal atrial fibrillation. When and how?].
Lévy S; Ricard P; Yapo F; Mansouri C
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():19-24. PubMed ID: 8734159
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation and atrial flutter.
Geraets DR; Kienzle MG
Clin Pharm; 1993 Oct; 12(10):721-35; quiz 783-4. PubMed ID: 7903069
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
[TBL] [Abstract][Full Text] [Related]
7. Drug therapy for atrial fibrillation.
Musco S; Conway EL; Kowey PR
Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation: drug therapies for ventricular rate control and restoration of sinus rhythm.
Chandramouli BV; Kotler MN
Geriatrics; 1998 Jun; 53(6):46-8, 51-2, 54, 57-60. PubMed ID: 9634106
[TBL] [Abstract][Full Text] [Related]
9. [Drug therapy of atrial fibrillation].
Fazekas T; Csanádi Z; Varró A
Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
Savelieva I; John Camm A
Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
[TBL] [Abstract][Full Text] [Related]
11. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
[TBL] [Abstract][Full Text] [Related]
12. Vernakalant hydrochloride for the treatment of atrial fibrillation.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation: pharmacological therapy.
Patel C; Salahuddin M; Jones A; Patel A; Yan GX; Kowey PR
Curr Probl Cardiol; 2011 Mar; 36(3):87-120. PubMed ID: 21392636
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
Camm J
Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
[TBL] [Abstract][Full Text] [Related]
15. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
[TBL] [Abstract][Full Text] [Related]
17. [Drug therapy of atrial fibrillation].
Gloor HO
Schweiz Med Wochenschr; 1996 Oct; 126(41):1739-47. PubMed ID: 8966506
[TBL] [Abstract][Full Text] [Related]
18. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
[TBL] [Abstract][Full Text] [Related]
19. Management of atrial fibrillation.
Hersi A; Wyse DG
Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological restoration and maintenance of sinus rhythm by antiarrhythmic agents].
Sugi K
J Cardiol; 1999 Mar; 33 Suppl 1():59-64. PubMed ID: 10342138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
